Pre-surgery red and infrared light to reduce swelling after open rhinoplasty with osteotomies
Official title: Effects of Photobiomodulation With Red and Infrared Low-level Laser Diodes in Individuals Undergoing Rhinoplasty at a Single Centre: Protocol for a Randomized, Double-blind, Controlled Clinical Trial
Run by University of Nove de Julho · NCT07033039 · Data updated 2026-11-12
This will try a short preoperative session of red and infrared light in adults having primary open rhinoplasty with osteotomies to see if it reduces early periorbital swelling.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Nove de Julho Academic / other |
| Locations | 1 site (São Paulo, São Paulo) |
| Status | Recruiting |
| Started | January 30, 2026 |
| Main results expected | November 30, 2029 |
| Study ends | November 30, 2030 |
| Registry record updated | March 24, 2026 |
| Trial ID | NCT07033039 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults (18–60 years) with ASA I–II status scheduled for primary open rhinoplasty with piezo-assisted osteotomies and no significant comorbidities or contraindicated medications.
✕Probably not a fit
Patients undergoing closed or non‑piezo procedures, those on anticoagulants, anti‑inflammatories or corticosteroids, those with recent nasal fillers or isotretinoin use, or with significant comorbidities or intraoperative complications are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, randomized, double-blind, sham-controlled trial will enroll 60 adults undergoing primary open rhinoplasty with piezo-assisted osteotomies and randomize them 1:1 to active or sham photobiomodulation (660 nm and 808 nm) one hour before surgery. Intervention and sham procedures use identical application steps to maintain masking, and assessors are blinded; surgical and perioperative care are standardized across participants. The primary outcome is periorbital edema on postoperative day 3 measured with a validated ordinal clinical scale and standardized photographs, and secondary outcomes include ecchymosis, pain, analgesic use, nasal tip skin thickness, and patient-reported aesthetic and functional outcomes. Participants will be followed for up to 12 months to capture longer-term functional and cosmetic results.
Why it matters
Potential benefit: If effective, preoperative photobiomodulation could reduce early swelling and bruising after rhinoplasty, shortening recovery time and improving comfort and cosmetic outcomes.
How similar studies have gone: Small randomized and observational studies of low‑level laser or LED photobiomodulation in facial and postoperative settings have reported reductions in swelling and pain, but high‑quality sham‑controlled data specifically in rhinoplasty remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * individuals 18-60 years of age; * ASA I or II; no comorbidities (no pre-existing diseases); * indication for rhinoplasty; * regardless of gender identity. Exclusion criteria: * use of anticoagulant, * anti-inflammatory, or corticosteroid medications; * indication for closed rhinoplasty; * procedures not performed using the Piezo device (Schuster SW Surgery II); * intraoperative complications (e.g., haemorrhage or technical difficulties); * prior nasal filler with hyaluronic acid; * use of vitamin A derivatives (oral isotretinoin or topical retinoic acid) within 30 days before surgery; * or known allergy to any mandatory intra- or postoperative medication.
Where it's running
-
Hospital Paulista de Otorrinolaringologia
São Paulo, São Paulo, Brazil Recruiting
Study contacts
- Principal investigator: Cinthya CG Duran, PhD — University of Nove de Julho
- Study coordinator: Cinthya CG Duran, PhD
- Email: cinthya.cgduran@gmail.com
- Phone: 5511981628831
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Patient-reported outcomes and complications after structural rhinoplasty with septal extension grafts
This project will track adults having their first structural rhinoplasty with a septal extension graft to see how their symptoms, satisfaction, and any complications change over the first six months after surgery.
-
Lateral crural steal plus columellar strut graft to improve nasal tip projection and rotation in primary open rhinoplasty
This trial tests whether combining a lateral crural steal technique with a columellar strut graft helps people having primary open rhinoplasty achieve and maintain better nasal tip projection and rotation.
-
Maxillary nerve block before septorhinoplasty to reduce opioid needs
This trial will test whether giving a bilateral maxillary nerve block before general anesthesia reduces intraoperative remifentanil use and improves postoperative pain for adults having elective septorhinoplasty.
-
Combining Ketamine and Magnesium for Pain Relief After Nose Surgery
This study is testing whether combining ketamine and magnesium during nose surgery can help reduce pain and lower the need for opioids afterward.
-
Comparing single and multiple surgeries for nasal and alveolar repairs in cleft lip and palate patients
This study is testing whether doing all the necessary nose and gum repairs in one surgery is better than spreading them out over multiple surgeries for kids with cleft lip and palate.
-
Evaluating a new surgical approach for upper arm lymphedema
This study is testing if adding a special collagen mesh to standard surgery can help people with upper arm lymphedema feel better and reduce swelling.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.